MYCN and neuroblastoma: Based on established prognostic factors, including age, disease stage, MYCN amplification status, ploidy, segmental chromosomal aberrations at 1p and 11q, and international neuroblastoma pathology classification (INPC), neuroblastoma is divided into three risk-based categories: low-, intermediate- and high-risk groups (1).